Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Gene: Fam115e (family with sequence similarity 115, member E) Rattus norvegicus
Analyze
Symbol: Fam115e
Name: family with sequence similarity 115, member E
Description: Predicted to have ion channel binding activity. Predicted to be involved in negative regulation of anion channel activity and positive regulation of protein targeting to membrane. Predicted to localize to the plasma membrane. Orthologous to human TCAF2 (TRPM8 channel associated factor 2); INTERACTS WITH bisphenol A; testosterone.
Type: protein-coding
RefSeq Status: PROVISIONAL
Also known as: Eapa2; experimental autoimmune prostatitis antigen 2; experimental autoimmune prostatitis antigen 2 homolog; MGC72615; similar to experimental autoimmune prostatitis antigen 2; Tcaf3; TRPM8 channel-associated factor 3
Orthologs:
No known orthologs. homologs ...
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rnor_6.0472,010,583 - 72,023,952 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.04136,805,319 - 136,818,688 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.4470,401,082 - 70,419,847 (-)NCBIRGSC3.4rn4RGSC3.4
RGSC_v3.1470,677,215 - 70,695,977 (-)NCBI
Celera466,429,381 - 66,443,692 (-)NCBICelera
Cytogenetic Map4q24NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene-Chemical Interaction Annotations
Gene Ontology Annotations
References - curated
References - uncurated

Genomics

QTLs in Region (Rnor_6.0)
miRNA Target Status

Sequence

Nucleotide Sequences
Protein Sequences
Transcriptome
Promoters

Strain Variation

Strain Sequence Variants (Rnor 5.0)

Additional Information

External Database Links
Nomenclature History
 
More on Fam115e
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

RGD Object Information
RGD ID: 1359405
Created: 2005-07-29
Species: Rattus norvegicus
Last Modified: 2019-04-12
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.